A detailed history of Entry Point Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 2,631 shares of MRK stock, worth $249,024. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,631
Previous 4,386 40.01%
Holding current value
$249,024
Previous $498,000 47.59%
% of portfolio
0.12%
Previous 0.29%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$96.31 - $114.76 $169,024 - $201,403
-1,755 Reduced 40.01%
2,631 $261,000
Q3 2024

Nov 13, 2024

BUY
$111.15 - $128.97 $397,361 - $461,067
3,575 Added 440.81%
4,386 $498,000
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $100,401 - $107,830
811 New
811 $100 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $240B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.